0
Does a non hodgkin lymphoma survivor have to live with a weak immune system?
Wiki User
∙ 9y agoWant this question answered?
Be notified when an answer is posted
Add your answer:
Earn +20 pts
Is lymphoma a blood cancer?
Yes, lymphoma is a type of blood cancer. Lymphoma specifically affects the lymphatic system, which is a part of the circulatory and immune systems. The lymphatic system includes lymph nodes, spleen, thymus, and bone marrow. Lymphomas are cancers that originate in the lymphocytes, a type of white blood cell that plays a crucial role in the immune system. There are two main types of lymphoma: Hodgkin Lymphoma (HL): Hodgkin lymphoma is characterized by the presence of Reed-Sternberg cells, which are abnormal giant cells. It usually starts in the lymph nodes and can spread to other parts of the lymphatic system and, in advanced stages, to other organs. Hodgkin lymphoma is less common than non-Hodgkin lymphoma. Non-Hodgkin Lymphoma (NHL): Non-Hodgkin lymphoma is a more diverse group of lymphomas that includes various subtypes. Unlike Hodgkin lymphoma, non-Hodgkin lymphoma can originate from different types of lymphocytes, and it may involve lymph nodes, lymphoid tissues, or organs throughout the body. Both Hodgkin and non-Hodgkin lymphomas are considered blood cancers because they affect the blood-forming tissues and cells within the lymphatic system. These cancers can lead to the abnormal growth and accumulation of lymphocytes, disrupting the normal function of the immune system. Diagnosis and treatment of lymphomas involve various methods, including imaging studies, biopsies, and laboratory tests. Treatment may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, or a combination of these approaches, depending on the specific type and stage of the lymphoma.
A cancer that affects the tissues of the lymphatic system?
The cancer that affects the tissues of the lymphatic system is called lymphoma. Lymphoma is a type of cancer that develops in the lymphatic system, which is part of the body's immune system. The lymphatic system includes lymph nodes, lymphatic vessels, the spleen, thymus, and bone marrow. There are two main types of lymphoma: Hodgkin lymphoma (HL): Hodgkin lymphoma is characterized by the presence of Reed-Sternberg cells, large abnormal cells found in the lymph nodes. It can occur at any age but is most common in young adults. Hodgkin lymphoma is often highly treatable, with a good prognosis, especially when diagnosed and treated early. Non-Hodgkin lymphoma (NHL): Non-Hodgkin lymphoma encompasses a diverse group of lymphomas that do not involve Reed-Sternberg cells. There are many subtypes of non-Hodgkin lymphoma, each with its own characteristics and treatment considerations. Non-Hodgkin lymphoma can occur in people of all ages and tends to be more common than Hodgkin lymphoma. Both Hodgkin and non-Hodgkin lymphomas can present with symptoms such as enlarged lymph nodes, fever, night sweats, weight loss, fatigue, and itching. Treatment for lymphoma typically involves chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches, depending on the type and stage of the disease. Early detection and appropriate treatment are crucial for improving outcomes in patients with lymphoma.
Which is worse hodgkins or non hodgkins lymphoma?
Non-Hodgkin lymphomas (NHL) are a diverse group of cancers which arise from lymphocytes, a type of white blood cell. NHL is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The broad category of non-Hodgkin lymphoma encompasses diseases with varying courses, treatments, and prognoses.Non-Hodgkin lymphoma is medically classified as a hematological malignancy, meaning that it is a cancer which arises from the blood. Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system, such as the spleen, lymph nodes, or tonsils. The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness. These categories are indolent (or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy. Some forms of non-Hodgkin lymphoma can be cured with chemotherapy, radiation, or hematopoietic stem cell transplantation.There were 55,216 cases of non-Hodgkin lymphoma diagnosed in the United States in 2005 (the most recent year for which statistics area available), and in that year, 20,873 people died from non-Hodgkin lymphoma.
What is non-hodgkin lymphoma?
Non-Hodgkin lymphomas (NHL) are a diverse group of cancers which arise from lymphocytes, a type of white blood cell. NHL is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The broad category of non-Hodgkin lymphoma encompasses diseases with varying courses, treatments, and prognoses.Non-Hodgkin lymphoma is medically classified as a hematological malignancy, meaning that it is a cancer which arises from the blood. Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system, such as the spleen, lymph nodes, or tonsils. The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness. These categories are indolent (or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy. Some forms of non-Hodgkin lymphoma can be cured with chemotherapy, radiation, or hematopoietic stem cell transplantation.There were 55,216 cases of non-Hodgkin lymphoma diagnosed in the United States in 2005 (the most recent year for which statistics area available), and in that year, 20,873 people died from non-Hodgkin lymphoma.
What's Hodgkin Lymphoma?
Non-Hodgkin lymphomas (NHL) are a diverse group of cancers which arise from lymphocytes, a type of white blood cell. NHL is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The broad category of non-Hodgkin lymphoma encompasses diseases with varying courses, treatments, and prognoses.Non-Hodgkin lymphoma is medically classified as a hematological malignancy, meaning that it is a cancer which arises from the blood. Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system, such as the spleen, lymph nodes, or tonsils. The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness. These categories are indolent (or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy. Some forms of non-Hodgkin lymphoma can be cured with chemotherapy, radiation, or hematopoietic stem cell transplantation.There were 55,216 cases of non-Hodgkin lymphoma diagnosed in the United States in 2005 (the most recent year for which statistics area available), and in that year, 20,873 people died from non-Hodgkin lymphoma.
What is Hodgkin Lymphoma?
Non-Hodgkin lymphomas (NHL) are a diverse group of cancers which arise from lymphocytes, a type of white blood cell. NHL is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The broad category of non-Hodgkin lymphoma encompasses diseases with varying courses, treatments, and prognoses.Non-Hodgkin lymphoma is medically classified as a hematological malignancy, meaning that it is a cancer which arises from the blood. Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system, such as the spleen, lymph nodes, or tonsils. The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness. These categories are indolent (or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy. Some forms of non-Hodgkin lymphoma can be cured with chemotherapy, radiation, or hematopoietic stem cell transplantation.There were 55,216 cases of non-Hodgkin lymphoma diagnosed in the United States in 2005 (the most recent year for which statistics area available), and in that year, 20,873 people died from non-Hodgkin lymphoma.
What is the cause of Hodgkin's disease?
usually begins in a lymph node. The node enlarges and--similar to enlarged lymph nodes due to infectious causes--may or may not cause any pain . Hodgkin's lymphoma progresses in a fairly predictable way, traveling
Which kind of cancer are common among people with aids?
coke
What is lymphoma cancer?
i belive it is called lymphoma and it is cancer of the lymph nodes.
What is cutaneous T-cell lymphoma?
Cutaneous T-cell lymphoma (CTCL) is a malignancy of the T-helper (CD4+) cells of the immune system.
What is cutaneous t cell lymphoma?
Cutaneous T-cell lymphoma (CTCL) is a malignancy of the T-helper (CD4+) cells of the immune system.
How is Hodgkin's disease described?
can occur at any age, although the majority of these lymphomas occur in people aged 15-34, and over the age of 60. Lymphoma is a cancer of the lymphatic system. Depending on the specific type, a lymphoma can have
